improving outcomes for patients with metastatic nsclc with immunotherapy
Published 2 years ago • 86 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
0:58
how can we improve outcomes for patients with kidney cancer who receive immunotherapy?
-
0:32
improving patient-reported outcomes in nsclc
-
1:42
improving responses to immunotherapy for patients with endometrial cancer
-
2:06
therapeutic advances improving surgical outcomes for metastatic disease
-
4:03
improved outcomes for patients with egfr nsclc
-
1:51
enhancing immunotherapy response prediction in nsclc
-
3:43
immunotherapy for operable lung cancer
-
15:25
targeted therapies: the future of non-small cell lung cancer (nsclc) treatment?
-
1:13
immunotherapy in stage iii nsclc metastatic disease
-
2:14
first-line treatment decision making for elderly patients with nsclc
-
2:20
selecting patients with nsclc who benefit from immunotherapy or targeted therapies
-
5:03
immunotherapy in metastatic nsclc
-
7:31
outcomes of first-line pembrolizumab monotherapy for pd-l1–positive metastatic nsclc
-
4:23
management of patients with pdl1-high advanced nsclc
-
2:41
major changes in treatments for patients with metastatic squamous cell lung cancer
-
1:56
improving outcomes in hcc with immunotherapy
-
17:30
immunotherapy in lung cancer: panacea vs. reality?
-
1:02:02
improving outcomes in molecularly altered nsclc through precision testing and treatment
-
6:08
flaura study: a new standard of care for patients with egfr mutated nsclc